retatrutide cardiovascular Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C Retatrutide for Weight Loss: TRIUMPH-1

All products are sold in powder (lyophilized) form

Brain 146, 37053718

A Phase 1 proof-of-concept trial evaluated the safety and tolerability of several ascending doses of LY in type 2 diabetic patients (T2D)

PT-141 Peptide Sexual Health and the Regulatory Picture: Why FDA Approval Matters PT-141's FDA approval in June 2019 is not a technical footnote

60% of patients achieved 20% or more weight loss, and 23% achieved 30% or more

60 Medullary thyroid cancer There is a theoretical increased risk of medullary thyroid cancer (MTC) as preclinical studies showed a link between GLP-1 receptor agonism to the development of C-cell hyperplasia and MTC in rodents